Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Eli Lilly and Company reported that the 2nd Circuit of the Labor Court of Paulinia in the state of Sao Paulo, Brazil, has ruled against the company's local subsidiary, Eli Lilly do Brasil, in a labor case alleging some employees were exposed...

FDA has approved AstraZeneca's Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridaemia (triglyceride levels greater than or equal to 500 mg/dL). Epanova is the...

Merck & Co. has received FDA approval for Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or...

Shire plc has agreed to acquire Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a fibrosis for an upfront payment of $75M and certain contingent payments based on the achievement of development and...

BioMarin Manufacturing Ireland, a subsidiary of BioMarin Pharmaceutical Inc.,announced that it expects to expand its Dublin operation, according to IDA Ireland, the economic development agency of Ireland. The Dublin operation has responsibility for...

Watson Laboratories, Inc, a subsidiary of the generic-drug company Actavis plc, has filed suit against FDA, challenging the agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex®...